FANCI
Basic information
Region (hg38): 15:89243945-89317261
Previous symbols: [ "KIAA1794" ]
Links
Phenotypes
GenCC
Source:
- Fanconi anemia complementation group I (Strong), mode of inheritance: AR
- Fanconi anemia complementation group I (Definitive), mode of inheritance: AR
- Fanconi anemia (Supportive), mode of inheritance: AR
- Fanconi anemia complementation group I (Definitive), mode of inheritance: AR
Clinical Genomic Database
Source:
| Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
|---|---|---|---|---|---|
| Fanconi anemia, complementation group I | AR | Allergy/Immunology/Infectious; Cardiovascular; Hematologic; Oncologic | Specific treatments can help manifestations (eg, oral androgens for blood counts; G-CSF for neutrophil count); HSCT can be curative, but solid tumor risk may remain; Surveillance for complications such as bone marrow failure is recommended; Fanconi anemia can involve congenital cardiac (and other) anomalies, and awareness may allow early management | Audiologic/Otolaryngologic; Allergy/Immunology/Infectious; Cardiovascular; Dermatologic; Gastrointestinal; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic; Renal | 14630800; 17452773; 17460694; 17412408; 20301575; 21568838 |
ClinVar
This is a list of variants' phenotypes submitted to
- Fanconi_anemia (1836 variants)
- Fanconi_anemia_complementation_group_I (602 variants)
- not_provided (213 variants)
- Inborn_genetic_diseases (105 variants)
- not_specified (81 variants)
- FANCI-related_disorder (37 variants)
- Fanconi_anemia_complementation_group_A (5 variants)
- POLG-Related_Spectrum_Disorders (4 variants)
- Hereditary_cancer-predisposing_syndrome (2 variants)
- Immunodeficiency_62 (2 variants)
- Microcephaly (2 variants)
- Colorectal_cancer (1 variants)
- Gastric_cancer (1 variants)
- Mitochondrial_disease (1 variants)
- Malignant_tumor_of_breast (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the FANCI gene is commonly pathogenic or not. These statistics are base on transcript: NM_001113378.2. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 436 | 450 | ||||
| missense | 819 | 25 | 857 | |||
| nonsense | 36 | 41 | 78 | |||
| start loss | 1 | 2 | 3 | |||
| frameshift | 50 | 80 | 134 | |||
| splice donor/acceptor (+/-2bp) | 63 | 70 | ||||
| Total | 95 | 189 | 838 | 461 | 9 |
Highest pathogenic variant AF is 0.00012020229
GnomAD
Source:
| Gene | Type | Bio Type | Transcript | Coding Exons | Length |
|---|---|---|---|---|---|
| FANCI | protein_coding | protein_coding | ENST00000310775 | 37 | 73313 |
| pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
|---|---|---|---|---|---|---|
| 8.91e-37 | 0.000982 | 125498 | 0 | 250 | 125748 | 0.000995 |
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
|---|---|---|---|---|---|---|
| Missense | -1.35 | 747 | 650 | 1.15 | 0.0000325 | 8740 |
| Missense in Polyphen | 114 | 118.33 | 0.96338 | 1739 | ||
| Synonymous | -1.78 | 274 | 239 | 1.15 | 0.0000127 | 2471 |
| Loss of Function | 1.37 | 63 | 75.9 | 0.830 | 0.00000377 | 971 |
LoF frequencies by population
| Ethnicity | Sum of pLOFs | p |
|---|---|---|
| African & African-American | 0.00181 | 0.00181 |
| Ashkenazi Jewish | 0.0000993 | 0.0000992 |
| East Asian | 0.000829 | 0.000816 |
| Finnish | 0.00337 | 0.00338 |
| European (Non-Finnish) | 0.000634 | 0.000633 |
| Middle Eastern | 0.000829 | 0.000816 |
| South Asian | 0.00124 | 0.00124 |
| Other | 0.000978 | 0.000978 |
dbNSFP
Source:
- Function
- FUNCTION: Plays an essential role in the repair of DNA double- strand breaks by homologous recombination and in the repair of interstrand DNA cross-links (ICLs) by promoting FANCD2 monoubiquitination by FANCL and participating in recruitment to DNA repair sites. Required for maintenance of chromosomal stability. Specifically binds branched DNA: binds both single- stranded DNA (ssDNA) and double-stranded DNA (dsDNA). Participates in S phase and G2 phase checkpoint activation upon DNA damage. {ECO:0000269|PubMed:17412408, ECO:0000269|PubMed:17452773, ECO:0000269|PubMed:17460694, ECO:0000269|PubMed:19111657}.;
- Disease
- DISEASE: Fanconi anemia complementation group I (FANCI) [MIM:609053]: A disorder affecting all bone marrow elements and resulting in anemia, leukopenia and thrombopenia. It is associated with cardiac, renal and limb malformations, dermal pigmentary changes, and a predisposition to the development of malignancies. At the cellular level it is associated with hypersensitivity to DNA-damaging agents, chromosomal instability (increased chromosome breakage) and defective DNA repair. {ECO:0000269|PubMed:17412408, ECO:0000269|PubMed:17452773, ECO:0000269|PubMed:17460694}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- Fanconi anemia pathway - Homo sapiens (human);Gastric Cancer Network 2;TP53 Regulates Transcription of DNA Repair Genes;Fanconi Anemia Pathway;DNA Repair;Gene expression (Transcription);Generic Transcription Pathway;RNA Polymerase II Transcription;TP53 Regulates Transcription of DNA Repair Genes;Fanconi anemia pathway;Transcriptional Regulation by TP53
(Consensus)
Recessive Scores
- pRec
- 0.203
Intolerance Scores
- loftool
- 0.265
- rvis_EVS
- -0.12
- rvis_percentile_EVS
- 44.54
Haploinsufficiency Scores
- pHI
- 0.351
- hipred
- Y
- hipred_score
- 0.550
- ghis
- 0.661
Essentials
- essential_gene_CRISPR
- E
- essential_gene_CRISPR2
- E
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.747
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | High | High | High |
| Primary Immunodeficiency | High | High | High |
| Cancer | High | High | High |
Mouse Genome Informatics
- Gene name
- Fanci
- Phenotype
- mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span);
Gene ontology
- Biological process
- cell cycle;positive regulation of protein ubiquitination;interstrand cross-link repair
- Cellular component
- nucleoplasm;cytosol;membrane
- Molecular function
- DNA binding;protein binding;DNA polymerase binding